Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

May 4, 2017

Singapore Researchers Develop Probe That Improves Liver Cancer MRI Imaging

Liver cancer, News

Researchers at the National University of Singapore have developed a probe that provides doctors with clearer and more accurate magnetic resonance images of liver cancer. The MRI tool will help doctors ... Read more

April 28, 2017May 12, 2017

FDA Approves Stivarga as Treatment for Common Form of Liver Cancer

Liver cancer, News

The U.S. Food and Drug Administration (FDA) approved the use of Stivarga (regorafinib) for the treatment of patients with hepatocellular carcinoma (HCC), a form of liver cancer, who progressed after ... Read more

April 26, 2017

Fecal Transplant Improves Cognitive Malfunction Caused by Liver Disease, Study Finds

News

Transplanting fecal bacteria from a healthy person to someone who has a liver-connected brain impairment may be an effective way to treat the condition, known as hepatic encephalopathy, a Norwegian ... Read more

March 29, 2017March 30, 2017

Insulin Resistance Linked to Poor Brain Function in Patients with Heart Disease, Study Shows

News, Non-alcoholic fatty liver disease

Insulin resistance (IR) is associated with poorer cognitive performance and greater cognitive decline in heart disease patients with or without diabetes, a new study says. The study, “Insulin Resistance And Future ... Read more

March 24, 2017March 30, 2017

Inhibiting Ion Pump May Prevent Non-Alcoholic Fatty Liver Disease, Mouse Study Shows

News, Non-alcoholic fatty liver disease

A peptide called pNaKtide has shown promise in improving the clinical manifestations associated with non-alcoholic fatty liver disease (NAFLD) and atherosclerosis, according to researchers at Marshall University’s Joan C. Edwards School ... Read more

March 17, 2017March 30, 2017

Liver Cancer Cells Find Alternatives When Fat, Their Main Fuel, Disappears

Liver cancer, News

Scientists have long believed that liver cancer cells needed fat molecules to survive, and that by blocking fat production, the cancer would starve. But a new Australian study shows this may not be ... Read more

March 16, 2017April 5, 2017

Coffee Intake May Reduce Risk of Chronic Liver Disease, Study Says

Alcoholic liver disease, Hepatitis, Liver cirrhosis, News, Non-alcoholic fatty liver disease

Drinking coffee may reduce the risk of chronic liver disease, especially in patients with other conditions affecting the liver, including non-alcoholic fatty liver disease, according to a new study. But ... Read more

March 7, 2017March 30, 2017

Chemo, Immunotherapy Combo May Help Fight Liver Cancer, Study Says

Liver cancer, News

Combining the chemotherapy agent Sutent (sunitinib) and immunotherapy may be a promising strategy to fight hepatocellular carcinoma, the most common type of liver cancer, according to a recent animal study. ... Read more

February 27, 2017

Cirrhosis Patients at Much Lower Risk of Liver Cancer Than Previously Thought

News

Patients with cirrhosis (liver damage) may be at a much lower risk of liver cancer than originally assumed, according to results of a recent study with U.K. patients, published in ... Read more